InsiderLens

fi_swedentransaction_report07 Mar 2025fi_sweden:3bb9a418c7489aa74bafd70a3e203957

fi_swedentransaction_report12 Feb 2025fi_sweden:b4a92c46f1a76e4da07f20f43dcccec3

fi_swedentransaction_report12 Feb 2025fi_sweden:f7a2e4a59154e3b0d3566db16ca3fd0f

fi_swedentransaction_report12 Feb 2025fi_sweden:cb39a2faea97a7fd9c623a95aa1fac4d

fi_swedentransaction_report12 Feb 2025fi_sweden:6c8c6354250164247c2be3c5a0897abe

fi_swedentransaction_report12 Feb 2025fi_sweden:3d0c1706bb59e58b9f48657bf5126703

fi_swedentransaction_report12 Feb 2025fi_sweden:2362845e9b9ded1fe3413575f4a72fb8

fi_swedentransaction_report12 Feb 2025fi_sweden:9e031003683364ad05ec29559670e133

fi_swedentransaction_report12 Feb 2025fi_sweden:1f8472a0c8ae4bef6a9b60c0cbf8ccff

fi_swedentransaction_report11 Feb 2025fi_sweden:8c4c5e324b0b8fea87a4615893f4f2ca

fi_swedentransaction_report11 Feb 2025fi_sweden:6674adc15f2784c4ccda81d4b0a0482c

fi_swedentransaction_report11 Feb 2025fi_sweden:169036de64a85909ea02142c05b8ad42

fi_swedentransaction_report11 Feb 2025fi_sweden:58df669ba5febd30f485706cae12c352

fi_swedentransaction_report11 Feb 2025fi_sweden:e570b9611711d83bbf30979f2f53bd45

fi_swedentransaction_report10 Feb 2025fi_sweden:0acbbbe36268ae15d597313e7755010d

fi_swedentransaction_report10 Feb 2025fi_sweden:b1d8c550ace4c49d0c62063a53757f2b

fi_swedentransaction_report10 Feb 2025fi_sweden:dfe18e3f018cafc19af44fe748df1d0e

fi_swedentransaction_report09 Feb 2025fi_sweden:8c6e55fb29e4ea25abc88980d49f93de

fi_swedentransaction_report09 Feb 2025fi_sweden:318c130b63bb93c1e99bbdbe92025ef3

fi_swedentransaction_report09 Feb 2025fi_sweden:9ab8e5cbf2bebed80c79e5724ec47efb

fi_swedentransaction_report15 Aug 2024fi_sweden:1601ddb53e77e1f899a0b52af406f454

fi_swedentransaction_report15 Aug 2024fi_sweden:2d809300bbb45c9f8969feeeaecff2de

fi_swedentransaction_report15 Aug 2024fi_sweden:b9a6bc4c3ed053c96063cd9abc8ba981

fi_swedentransaction_report15 Aug 2024fi_sweden:113e3dc0171a85eda5c64f45e8f074ed

fi_swedentransaction_report03 Jun 2024fi_sweden:f22b24ef2a95e22d39bf4b29440e1d6b

NeuroVive Pharmaceutical AB.